Posted by Max Byerly on Dec 22nd, 2024
BioAtla, Inc., a clinical-stage company specializing in Conditionally Active Biologics (CABs), disclosed an important corporate update through an 8-K filing dated December 20, 2024. In this filing, BioAtla outlined its recent activities...
More of this article »